ABBVIE CARE TERMS & CONDITIONS AND PRIVACY STATEMENT

TERMS AND CONDITIONS

  1. Only Australian residents who have been prescribed and dispensed an AbbVie Medication for an indication and dosing schedule registered with the Therapeutic Goods Administration (Medication) (together, Medications) by their healthcare professional are eligible to enrol in and continue their participation in an AbbVie Care patient support program.
  2. Not all Medications will have a patient support program under AbbVie Care. Those Medications eligible for a patient support program will have a dedicated program specific to the prescribed Medication (Program) (together, Programs).
  3. If enrolment into a Program is for a patient prescribed a paediatric indication of a Medication, and the patient is under 18 years of age, a legal parent/carer/guardian can give consent for the patient to be enrolled in a Program.
  4. Programs are sponsored by AbbVie Pty Ltd (ABN 48 156 384 262) (AbbVie) and managed and administered by AbbVie’s nominated third party providers (Service Providers). Service Providers facilitate the provision of all communications, including phone calls, mail, emails, SMS and any future digital communication channels that may become available for the Programs.
  5. Each Program may offer a range of health, wellness and treatment logistics services. The range of activities and services offered is specific to each Medication and will vary between Programs. Participation in a Program is designed to complement and support the prescribing instructions of a healthcare professional who is responsible for prescribing the Medication for a specific medical condition (Prescribing Specialist). All services offered under a Program are optional, allowing patients to opt into all or a selection of the available services.
  6. A Program does not replace the advice of a Prescribing Specialist or other healthcare professional (HCP). Patients should speak to their Prescribing Specialist if they have any questions or concerns about their treatment. Patients should also refer to their Medications’ Consumer Medicines Information available at www.medicines.org.au or by calling AbbVie Medical Information on 1800 043 460 if they have any further questions or concerns.
  7. The eligibility of a patient to remain enrolled in a Program is determined by the criteria outlined in clause 1 above, which will be verified on an ongoing basis by Service Providers (e.g. by asking the patient if they are still taking a Medication). AbbVie reserves the right to discontinue the provision of services to a patient under a Program, if a patient does not meet the eligibility criteria.
  8. Patients may opt out of any of the Services of a Program, at any time by calling 1800 222 843 or writing to: AbbVie Care Team at AbbVie Care, Reply Paid 86675, PO Box 6042, North Sydney NSW 2059 (no stamp required), follow the opt out instruction in SMS and email, or fax to 1800 219 836.
  9. Patients may opt out of an entire Program by calling 1800 222 843.
  10. If patients opt out of a Program, personal information collected from them during their participation in a Program may still be held for purposes permitted by law, including reporting purposes. To the extent personal information is retained, it will be handled in accordance with the Program Privacy Policy.
  11. AbbVie reserves the right to cease funding a Program and/or terminate any or all of the Programs with reasonable notice at any time.
  12. AbbVie reserves the right to change and/or cease providing any of the services within a Program with reasonable notice at any time.

Services

  1. The Programs may offer all or some of the following services:
  1. Self-Injection Training - involves training on appropriate self-injection technique. Following a patient’s enrolment, their personal information will be provided to a third-party nursing services agency that will contact the patient to arrange the training.

  2. Allied Health Support Products and Services - involves allied health support services from Service Providers. Following enrolment, an allied health professional will contact the patient to identify a health goal the patient wishes to work towards. The allied health professional may also provide information about additional support services. The Programs may also offer support products to patient to assist with quality use of their Medication.

  3. General Health and Wellness Information – involves regular communications covering a range of educational topics through different communication channels, reminders about optional Program offerings and offers to participate in surveys.

  4. Reminder Services – may involve reminder services regarding the timing of a patient’s Medication, the collection of the prescription, and appointments with their Prescribing Specialist. The Reminder Services provided by a Program are to assist with the usual medication reminder methods that a patient has adopted for the timing of their Medication, the collection of their prescription, and appointments with their Prescribing Specialist. Patients should not rely solely on this service to remind them of the actions required.

  5. Online and mobile platforms – involves access to a password protected, comprehensive range of online support services and management tips at “www.abbviecare.com.au” (Website), including support tools and information relating to the Medication.

  6. Medication Management Services – includes all of the following:

    1. Getting Started, includes a series of communications regarding whether or not a patient has received their prescription, guidance on the next steps of the logistics of their treatment journey, and preparing for the next pharmacy visit;
    2. Staying on Track includes communications at key times to assist with managing a patient’s appointment schedule (including with their Prescribing Specialist and appointments for pathology tests, if relevant);
    3. Pharmacy Liaison Services, includes reminder services and regular contact with a patient’s pharmacist to confirm their prescription is filled at the right times.
      The Staying on Track and Pharmacy Liaison communications are to assist patients with their usual reminder methods that they have adopted for managing their appointment schedules. Patients should not rely solely on these services to remind them of the actions required.
  1. As part of a patient’s participation in the Medication Management Services, and in order to provide patients with the associated Pharmacy Liaison Services, patients must nominate a pharmacy where they intend to fill their prescription (Pharmacy). Patients must consent to a Service Provider providing their name and contact information to the Pharmacy to correctly identify the patient. Following enrolment, a Service Provider will contact the Pharmacy and confirm the patient’s pharmacy ID number with the primary pharmacist (Pharmacist). The purpose of this process is to ensure the Pharmacist receives an outline of a patient’s Program and confirmation of their enrolment in that Program. This also allows a Service Provider to provide the Pharmacy Liaison Services, which includes confirming a patient’s prescription status each month, and providing the reminder services. Information obtained from the Pharmacy Liaison Service is shared with a patient’s Prescribing Specialist to assist with managing their treatment with the Medication.

How to enrol in a Program

  1. Patients may enrol in a Program either by:
  1. self-enrolment – at www.abbviecare.com.au by phoning 1800 222 843, emailing support@abbviecare.com.au, or by SMS to 0414 222 843;
  2. Prescribing Specialist’s referral (when available); or
  3. Pharmacist’s referral (when available).
  1. In order to enrol in a Program and opt into any or all of the available services, patients must acknowledge that they have understood and agreed to the AbbVie Care Terms and Conditions and the Program Privacy Policy.
  2. If a patient is referred for enrolment by their Prescribing Specialist, the patient’s contact information (email address and/or phone number) will be provided to a Service Provider, who will contact the patient to complete their enrolment.
  3. Prescribing Specialist enrolled in a Program can nominate additional staff (e.g. clinic nurses, clinic administrators or other authorised personnel) (Delegates) to communicate with Service Providers to assist with a patient’s participation in a Program.
  4. If patients are referred by their Pharmacist for enrolment, the patient’s contact information (email address and/or phone number) will be provided to a Service Provider, who will contact the patient to complete their enrolment. Pharmacists may receive a payment from AbbVie as a result of referring a patient for enrolment in a Program.

PRIVACY STATEMENT

Service Providers will collect, use, store and/or disclose personal information relating to a patient in connection with their participation in a Program. Service Providers use personal information primarily to manage a patient’s participation in a Program and for other purposes as notified to the patient. Service Providers will not use personal information for any other purposes unless Service Providers have consent to do so or is required to do so by law. If a patient does not provide personal information when requested, Service Providers will not be able to manage a patient’s participation in a Program and, as a result, the patient may not be able to participate. Service Providers take reasonable steps to protect such personal information from misuse, interference, loss and unauthorized access, modification or disclosure. Service Providers may share personal information with other selected third-party service providers (who may be located outside of Australia) in accordance with the AbbVie Care Privacy Policy. Personal information will be handled in accordance with the AbbVie Care Privacy Policy which details (amongst other things) how a patient can access, correct or complain about the handling of their personal information, and how Service Providers will respond to a patient’s requests or complaints. If a patient has any questions or if they would like a copy of a Program Privacy Policy, or if the patient would like to see or correct their records or has a complaint, please contact one of the Service Providers at any time by calling 1800 222 843 or writing to the AbbVie Care team at AbbVie Care, Reply Paid 86675, PO Box 6042, North Sydney NSW 2059 (no stamp required) or fax to 1800 219 836. Before submitting any information and agreeing to enrol in a Program, patients should be aware of and consent to the following:

FOR PATIENTS

Consent: By providing personal information (including your name, age, contact details; as well as, sensitive information relating to the medical condition being treated with the Medication), patients consent to Service Providers using their personal information for the following purposes:

• program administration and delivery of products and services;

• contacting healthcare professionals and providing them with information about the medicine and a patient’s participation and activities undertaken in a Program;

• reminding patients to take their Medication as prescribed;

• tailoring a Program to a patient;

• providing a patient with materials relating to their treatment and a Program;

• contacting patients to inform them of changes in a Program and to collect their feedback on a Program;

• for safety monitoring, reporting and auditing and responding to enquiries or issues in relation to their Medication.

• for participation in market research activities related to a Program

Collection and Use of Personal Information: Service Providers will collect personal information directly from patients and their Pharmacist. If a patient has been referred to a Program by their Prescribing Specialist, their personal information may be stored in a Program database which may be accessible by the patient’s Prescribing Specialist and any Delegates in accordance with these Terms and Conditions and the Program Privacy Policy. Service Providers may also disclose personal information to other persons involved with the Program for the purposes described above. Service Providers may use personal information to assess a patient’s interest in participating in market research or AbbVie sponsored research projects related to a Program.

Data Sharing with AbbVie: Any self-reported safety events (including adverse events, special situations and product complaints) that arise from taking a Medication will be reported to AbbVie for the purpose of reporting this information to the appropriate regulatory notification body and/or in accordance with AbbVie’s Safety Information reporting processes. AbbVie may also use the personal information to contact a patient and/or their healthcare professional to obtain additional information relating to the safety event (including adverse events, special situations and product complaints). AbbVie may also grant access for the purpose of information technology services for system administration only. De-identified information relating to a patient’s participation in a Program may be collated into a report for AbbVie. AbbVie may use this information to:

• help to develop and evaluate the Medications, the Programs, services, materials and treatment

• enable research, including future scientific research and publications to help future patients

• promote awareness of the Programs

AbbVie may also share de-identified information with its parent company AbbVie Inc. or its affiliates regarding how the Programs are working on an aggregated basis. This information does not identify patients individually. Any personal information collected by AbbVie will be handled in accordance with AbbVie’s privacy policy available at www.abbvie.com.au/privacy/home.html. Before agreeing to refer a patient for enrolment in a Program, Prescribing Specialists and other HCPs (collectively referred to as HCPs for the purposes of the below) should be aware of and consent to the following:

FOR PRESCRIBING SPECIALISTS AND HEALTHCARE PROFESSIONALS (together, HCPs)

Consent: By completing an enrolment to participate in a Program, HCPs consent to Service Providers collecting and using the personal information provided (e.g. name and contact details) to contact them in relation to a Program, including patient-related updates, feedback on a Program, and otherwise as necessary to undertake participation in the relevant Program.

Collection and Use of Personal Information: Service Providers may collect HCP personal information directly from the HCP or may source such information from AbbVie’s use of third-party databases (e.g. OneKey) to complete their registration details for a Program. Personal information held about an HCP will be linked to the patients under that HCP’s medical care. HCP personal information will be used for the purposes of administering the Program, including but not limited to safety event reporting, and may be disclosed to other third parties involved in the delivery of the Program.

Delegates: During the registration process, HCPs will be offered the opportunity to nominate Delegates to communicate with Service Providers to assist with a patient’s participation in a Program. Delegates registered against the associated Prescribing Specialist enrolled in the Program are linked to the Prescribing Specialist’s master account in the event online services are available. HCPs will provide any reasonable assistance requested from Service Providers to allow Service Providers to obtain any consents necessary to contact the HCP’s Delegates. The name of an HCP and their Delegate/s, their contact details, total number of patient enrolments, and channel of enrolment will be collated into a report for AbbVie. Patient specific information will not be included in any report provided to AbbVie. AbbVie may use this information for internal purposes, including planning and managing resources for a Program, and analysis and research purposes. AbbVie may disclose the information to third parties in order to promote awareness of the Program and to publish the information in reports or medical publications. The name of the Prescribing Specialist and their Delegate/s will not be able to be identified in any form of report or publication. Any personal information collected by AbbVie will be handled in accordance with AbbVie’s privacy policy available at www.abbvie.com.au/ privacy/home.html. If a Program has a digital platform, it may give Prescribing Specialists and their Delegate/s access to the following services:

  1. a digital pathway that allows Prescribing Specialists and their Delegate/s to refer patients for enrolment in a Program;
  2. a patient progress dashboard (Dashboard), which sets out the status of all a Prescribing Specialist’s patients. The Dashboard is provided to assist Prescribing Specialists with the methods that they have adopted for managing their patients and should not be relied on solely for managing patients; and
  3. additional information, including but not limited to, Product Information, PBS Information, Minimum Product Information, Consumer Medical Information, these Terms and Conditions and the Program Privacy Policy.

Personal Data of Patients:

By completing an enrolment to participate in a Program, HCPs and their Delegate/s confirm that they are authorised to collect a patient’s personal information (including email address and phone number), and that they have provided the necessary notifications to each patient (or their guardian) that they are nominating for enrolment into a Program. HCPs and their Delegate/s confirm that they have informed their patient that Service Providers may need to contact them to complete their enrolment into a Program.

How to Contact Us

If there are any questions in relation to privacy, please contact a Service Provider on 1800 222 843, or by writing to the AbbVie Care team at support@abbviecare.com.au or AbbVie Care, Reply Paid 86675, PO Box 6042, North Sydney NSW 2059 (no stamp required) or fax to 1800 219 836. AbbVie & AbbVie Care are registered trademarks of AbbVie Inc. AbbVie Pty Ltd. ABN 48 156 384 262. Mascot NSW 2020 Australia. CLA-AU-200045 November 2020 .